Hepatitis C Virus (HCV) is an enigma because it is recognized by both the cellular and humoral compartments of the immune system, yet it persists in at least 85% of those infected. Clearly, there must exist an immune deregulation of the response to HCV. We think that under host immune selection, there is an accumulation of HCV quasi species expressing functionally tolergenic epitopes conducive to viral persistence. We further postulate that as apart of the evolutionary process by which such functionally tolergenic epitopes are selected, helper T-cell responses shift towards a Th2 phenotype favoring chronic infection and creating a tolerogenic bias that specifically dampers effective anti-HCV responded even to wild-type virus.
The aims of this proposal are: 1) to establish a frequency hierarchy for clones recognizing Th1 epitopes in the NS3 antigen, a protein critical to HCV infection and replication. 2) to determine the mechanism of IL-2 suppression in response to an immunodominant epitope within the nine-structural (NS) 3 protein antigen of HCV. 3) to examine the relationship between viral nutation and functionally distinct helper T-cell epitopes that stimulate production of different cytokines. 4) to define the location and cytokine profiles of functionally distinct epitopes found in the nucleocapsid or Core protein antigen of HCV. We believe that understanding the structural constraints upon helper T-cell interactions with functionally distinct HCV epitopes provides a powerful vantage point from which to study immune regulation in humans and may lead to strategies for interviewing in the infectious process. Our studies are designed to test some of the in vitro correlates of this hypothesis and to gain insights into how natural variations in viral epitopes can lead to modulation of human T-cell responses. An understanding of this process is likely to bear on mechanisms and consequences of immune recognition as well as avenues of anti-viral therapeutic intervention. As we strive to address a number of important questions concerning HCV mutation and its effects on immune function, we postulate that this probably involves division of immune responses towards a Th2 or tolerogenic phenotype.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK057732-02
Application #
6517756
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Doo, Edward
Project Start
2001-03-15
Project End
2002-03-31
Budget Start
2002-03-01
Budget End
2002-03-31
Support Year
2
Fiscal Year
2002
Total Cost
$48,111
Indirect Cost
Name
Bloodcenter of Wisconsin, Inc.
Department
Type
DUNS #
City
Milwaukee
State
WI
Country
United States
Zip Code
53233
Cusick, Matthew F; Yang, Meiying; Gill, Joan C et al. (2011) Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection. Hum Immunol 72:379-85
Wang, Shuping; Buchli, Rico; Schiller, Jennifer et al. (2010) Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity. World J Gastroenterol 16:1953-69
Zhu, Fenlu; Yang, Meiying; Eckels, David D (2005) Interactions between helper T-cell epitopes of hepatitis C virus. Vaccine 23:3572-80
Yang, Meiying; Zhu, Fenlu; Sonderstrup, Grete et al. (2005) Recognition of endogenously synthesized HLA-DR4 restricted HCV epitopes presented by autologous EBV transformed B-lymphoblastoid cell line. Vaccine 23:951-62
Wang, Jane H; Layden, Thomas J; Eckels, David D (2003) Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response. Hum Immunol 64:662-73
Pleister, Adam; Eckels, David D (2003) Cryptic infection and autoimmunity. Autoimmun Rev 2:126-32
Wang, Huiru; Bian, Tonghua; Merrill, Stephen J et al. (2002) Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection. J Mol Evol 54:465-73
Zhu, Fenlu; Eckels, David D (2002) Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL. Hum Immunol 63:710-8